December 7, 2016 / 12:31 PM / in a year

BRIEF-3D signatures new initiative to distinguish between two forms of lung cancer

Dec 7 (Reuters) - 3d Signatures Inc

* 3D signatures inc - additional studies are being planned between iucpq and 3ds, to move 3ds’ novel biomarker closer to commercialization

* 3D signatures inc - 3d signatures molecular imaging technology shows potential in improving management of lung cancer patients with multiple lesions Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below